Healthcare Professionals Forum

This scientifically based medical cannabis forum is specifically for healthcare professionals. International and national experts will be presenting essential updates on the endocannabinoid system, clinical data, and the applications and prescribing of medicinal cannabis in medical practice. Essential for GPs, Pharmacists and other healthcare professionals who are critical to improving patient access.

Healthcare Professionals Forum – 11 February

08:50
09:20
  • Setting the scene – how medicinal cannabis is being used to heal illness?
  • Advocating for equity in access to medicinal cannabis for patients
Bonni Goldstein Medical Director, Canna Centers Wellness & Education
10:50
  • Cannabis as a medicine
  • Endogenous cannabinoid system
  • Safety data
  • Treating patients in the New Zealand setting
  • Global overview

Dr Mark Hotu Clinical Director, Green Doctors Medicinal Cannabis Clinic
11:20
  • Effectiveness, safety and appropriateness considerations
  • Drug interactions and pharmacogenetics relevant to cannabis with their implications
  • Dosing of CBD and THC
  • Contraindications and adverse effects
  • Presentation of several case studies of New Zealand patients receiving medical cannabis and their clinical responses

Elizabeth Plant Chief Medical Officer, Eqalis
11:50

Graham Gulbransen Cannabis Consultant, Addiction Specialist, General Practitioner, Cannabis Care
13:20
  • Medications currently used for chronic pain 
  • The commonly held belief that most medications are backed by evidence while medical cannabis is not
  • The actual evidence for currently recommended medications for chronic pain and where medical cannabis stands
Lionel Marks de Chabris MD Chief Medical Officer, ZYUS Life Sciences
13:50
James Yu Charge pharmacist and Co-Owner , Ngā Hua Pharmacy
14:50
Katy Thomas TV Presenter. Editor. Mother And Overnight Influencer
15:20

Martin Lee, Director, Project CBD

10:40
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
10:40
Ali Seyfoddin Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology
10:40
  • Nutrients
  • Grow media
  • Bio pesticides
10:40
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
10:40

What are considerations for the sector?

10:40

What are considerations for the sector?

Richard Keene Principal, KMSL
13:10
Andrea Eng Manager of Regulatory Practice & Analysis, Medicinal Cannabis Agency, Ministry of Health
13:10
Ali Seyfoddin Associate Professor of Drug Delivery and Biological Engineering Deputy Head of School, School of Science, Auckland University of Technology
13:10
  • Nutrients
  • Grow media
  • Bio pesticides
13:10
Steve Tallon Team Leader, Process Engineering Group, Callaghan Innovation
13:10

What are considerations for the sector?

13:10

What are considerations for the sector?

Richard Keene Principal, KMSL

Accreditation number: 2021/03, Expiry: 06/08/2023. The Health Professional sessions of this conference have been endorsed by The Pharmaceutical Society of New Zealand (PSNZ) and are suitable for Pharmacist’s continuing education.

The “MedCan Summit 2022” has been endorsed by The Royal New Zealand College of General Practitioners (RNZCGP) and has been approved for up to 11.25 CME credits for Continuing Professional Development (CPD) purposes.